MTOR and cancer: Additionally, UHRF1’s regulation of the PI3K/Akt/mTOR pathway in esophageal squamous cell carcinoma further illustrates the extensive impact of these proteins on cancer pathophysiology, offering novel insights into potential therapeutic targets.